{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "19958767", "DateCompleted": {"Year": "2010", "Month": "03", "Day": "30"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1016/j.ejphar.2009.11.061"], "ArticleDate": [{"Year": "2009", "Month": "12", "Day": "01"}], "Journal": {"ISSN": "1879-0712", "JournalIssue": {"Volume": "629", "Issue": "1-3", "PubDate": {"Year": "2010", "Month": "Mar", "Day": "10"}}, "Title": "European journal of pharmacology", "ISOAbbreviation": "Eur J Pharmacol"}, "ArticleTitle": "Antiarrhythmic effect of acute oxygen-ozone administration to rats.", "Pagination": {"StartPage": "89", "EndPage": "95", "MedlinePgn": "89-95"}, "Abstract": {"AbstractText": ["The antiarrhythmic effects of 100; 150; and 300microg/kg i.p. oxygen/ozone mixture were tested on arrhythmias induced by i) ischemia; ii) ischemia/reperfusion; iii) aconitine (15microg/kg/i.v.); potassium chloride (1.5% i.v.) in rats. 25min of cardiac left descending coronary artery ischemia caused severe incidence of ventricular tachycardia, ventricular fibrillation and mortality. These were significantly reduced by pre-treatment of rats with oxygen/ozone mixture at doses of 150 and 300microg/kg. In separate experiments using a protocol of 5min ischemia followed by 8min reperfusion this caused arrhythmias starting within 6+/-1s. The incidence of ventricular tachycardia was 100%, while ventricular fibrillation occurred in 75% of the animals and lasted 85+/-14s. The mortality was 62.5%. These figures were significantly (P<0.01) reduced in animals treated with 150microg/kg oxygen/ozone and a substantial increase observed with 300microg/kg, whilst not affected by the lower dose of 100microg/kg. 150 and 300microg/kg oxygen/ozone prolonged the onset time for the appearance of arrhythmias induced by aconitine (300microg/kg oxygen/ozone, approximately 81% longer). Oxygen/ozone also reduced the ventricular tachycardia duration, ventricular fibrillation incidence, arrhythmia score, and increased the rat's survival rate. As for example, this latter was increased from 25% (aconitine) to 50% (aconitine+oxygen/ozone 150microg/kg). 100microg/kg oxygen/ozone was without effect. None of the oxygen/ozone doses affected the arrhythmias caused by potassium chloride 1.5% i.v. All the oxygen/ozone antiarrhythmic effects were similar to those observed with lidocaine (1.5mg/kg i.v.). In conclusion, oxygen/ozone has antiarrhythmic effects against arrhythmias caused by aconitine, myocardial ischemia and ischemia/reperfusion."], "CopyrightInformation": "Copyright (c) 2009 Elsevier B.V. All rights reserved."}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Experimental Medicine, Section of Pharmacology L. Donatelli, 2nd University of Naples, Italy."}], "Identifier": [], "LastName": "Di Filippo", "ForeName": "Clara", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Cervone", "ForeName": "Carmela", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Rossi", "ForeName": "Claudia", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "di Ronza", "ForeName": "Cristina", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Marfella", "ForeName": "Raffaele", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Capodanno", "ForeName": "Paola", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Luongo", "ForeName": "Carlo", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Rossi", "ForeName": "Francesco", "Initials": "F"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "D'Amico", "ForeName": "Michele", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Eur J Pharmacol", "NlmUniqueID": "1254354", "ISSNLinking": "0014-2999"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Arrhythmia Agents"}, {"RegistryNumber": "660YQ98I10", "NameOfSubstance": "Potassium Chloride"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "S88TT14065", "NameOfSubstance": "Oxygen"}, {"RegistryNumber": "X8YN71D5WC", "NameOfSubstance": "Aconitine"}], "MeshHeadingList": [{"QualifierName": ["toxicity"], "DescriptorName": "Aconitine"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["administration & dosage", "pharmacology", "therapeutic use"], "DescriptorName": "Anti-Arrhythmia Agents"}, {"QualifierName": ["chemically induced", "drug therapy", "etiology"], "DescriptorName": "Arrhythmias, Cardiac"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["complications", "metabolism", "pathology", "physiopathology"], "DescriptorName": "Myocardial Ischemia"}, {"QualifierName": ["administration & dosage", "pharmacology", "therapeutic use"], "DescriptorName": "Oxygen"}, {"QualifierName": ["administration & dosage", "pharmacology", "therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": ["toxicity"], "DescriptorName": "Potassium Chloride"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["complications", "metabolism", "pathology", "physiopathology"], "DescriptorName": "Reperfusion Injury"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2009", "Month": "9", "Day": "28"}, {"Year": "2009", "Month": "11", "Day": "12"}, {"Year": "2009", "Month": "11", "Day": "23"}, {"Year": "2009", "Month": "12", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2009", "Month": "12", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "3", "Day": "31", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["19958767", "10.1016/j.ejphar.2009.11.061", "S0014-2999(09)01113-3"]}}], "PubmedBookArticle": []}